RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GARAJOVA I
Collezione AOU Città della Salute di Torino

Items : 5

A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] / Pancreatology. 2024 Nov;24(7):1066-1072. doi: 10.1016/j.pan.2024.09.006. Epub 2024 Sep 12.

2024
AOU Città della Salute di Torino

Carconi C; Bosi C; Scartozzi M; Cergnul M; Cinausero M; Faloppi L; Garajova I; Lonardi S; Pecora I; Pisanu L; Spadi R; Spallanzani A; Peretti U; Macchini M; Orsi G; Reni M;

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study. in Targeted oncology / Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.

2024
ASL Biella
AOU Città della Salute di Torino

Aldrighetti L; Ratti F; De Rosa A; Zanuso V; Niger M; Fornaro L; Rossari F; Satolli MA; Garattini SK; Brandi G; Brunetti O; Leone F; Diana A; Pirrone C; Toma I; Pretta A; Landriscina M; Lorenzo A; Gusmaroli E; Bergamo F; Balsano R; Winchler C; Salani F; Formica V; Schirripa M; Aprile G; Garajova I; Martinelli E; Rapposelli IG; et alii...

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2022 Mar;30(3):2455-2465. doi: 10.1007/s00520-021-06652-5. Epub 2021 Nov 15.

2022
ASL Torino 4
AOU Città della Salute di Torino

Ferri C; Parisi A; Ficorella C; Cortellini A; Pensieri MV; Aimar G; Roberto M; Petrillo A; Zoratto F; Spinelli GP; Garajova I; Vitale P; Zanaletti N; De Tursi M; Di Pietro FR; Morelli C; Giampieri R; Depetris I; Keränen SR; Lombardi P; Zurlo IV; Dell'Aquila E; Gelsomino F; Ghidini M; Nigro O; Filippi R; Salvatore L; Porzio G; Fargnoli MC; et alii...

Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study. in Clinical colorectal cancer / Clin Colorectal Cancer. 2021 Dec;20(4):318-325. doi: 10.1016/j.clcc.2021.07.003. Epub 2021 Jul 18.

2021
ASL Torino 4
AOU Città della Salute di Torino

D'Orazio C; Ficorella C; Petrillo A; Ierino D; Spinelli GP; Roberto M; Zoratto F; Ghidini M; Vitale P; Garajova I; Troiani T; Di Pietro FR; De Galitiis F; Zanaletti N; Tinari N; Morelli C; Giampieri R; De Tursi M; Aimar G; Depetris I; Lombardi P; Keränen SR; Claudia F; Leo S; Dell'Aquila E; Spallanzani A; Zurlo V; Gelsomino F; Nigro O; et alii...

Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study. in Frontiers in oncology / Front Oncol. 2021 Oct 27;11:712053. doi: 10.3389/fonc.2021.712053. eCollection 2021.

2021
ASL Torino 4
AOU Città della Salute di Torino

Porzio G; Ficorella C; Ferri C; D'Orazio C; Patruno L; Petrillo A; Aimar G; Zoratto F; Roberto M; Spinelli GP; Garajova I; Vitale P; Zanaletti N; Morelli C; Di Marino P; Di Pietro FR; Depetris I; Giampieri R; Roselló Keränen S; Fulgenzi C; Lombardi P; Zurlo IV; Gelsomino F; Nigro O; Ghidini M; Tortora G; Salvatore L; Filippi R; Venditti O; et alii...